Peptides 101

How to store peptides: storage and transit of lyophilized powder

MaterialPublished 3 October 2026Updated 19 October 20263 min read

A sealed lyophilized peptide is a dry solid, and chemistry in a dry solid is slow, so a few days near room temperature is a modest thermal exposure. Moisture, sustained heat and light speed that chemistry; storage at −20 °C slows it further.

Transit and storage are questions about a solid. A lyophilized vial holds the peptide as a dry, porous cake with very little water. Chemical change generally needs molecular mobility, and water acts as a plasticizer that supplies it. A dry cake offers little of either.

What degrades a dry peptide

The routes most often reported for dry peptides are deamidation (mainly at asparagine), oxidation (at methionine, cysteine and tryptophan) and backbone cleavage at aspartic acid; aggregation is also reported. Mobility helps all of them, and deamidation and cleavage need water itself. Residual moisture in the cake and humidity in the surrounding air supply it.

Heat accelerates each of them. In the usual Arrhenius range, a reaction rate rises roughly two- to four-fold for each 10 °C, a rule of thumb and not a measurement on any particular peptide. Light is a separate route to oxidation, covered in the companion article Light and peptides.

Why the solid state is forgiving

In an amorphous cake held below its glass transition temperature, molecular motion is very slow. Accelerated testing rests on the Arrhenius relationship: stress a product with heat, measure the change and extrapolate to milder conditions. The extrapolation holds only while the degradation mechanism stays the same, and for an amorphous solid it can fail as the stress temperature nears the glass transition. ICH Q1A(R2) is the stability guideline such studies follow; its conditions are the guideline's, not Solara's test results.

What transit does to a vial

A parcel moves between a warm truck and a cold depot, so it sees swings rather than a steady temperature. ICH Q1A(R2) sets no accelerated condition for material labelled for freezer storage; it asks for a separate study at 5 °C or 25 °C to cover shipping excursions. Where a cold pack is used, it buffers heat peaks; it does not hold −20 °C. Arrival at room temperature therefore shows neither that a vial has changed nor that it has not. Solara ships from Canada within one to two business days, packed to protect the powder in transit, and has published no stability data for its lots.

Storage once the vial arrives

Solara's site guidance is to store the lyophilized powder at −20 °C, sealed, protected from light and moisture. Each condition maps to one of the routes above:

  • Cold: rates fall with temperature, so −20 °C slows every route above.
  • Sealed: the closure is the barrier against humid air.
  • Dark: excluding light removes photo-initiated oxidation.
  • Dry: moisture is the input most routes depend on.

Solara's guidance is that a sealed vial reach room temperature before it is opened, so that water does not condense onto the cake.

What this does not establish

  • This article does not interpret the expiry date on a Solara label.
  • General literature values do not predict the stability of any particular lot.
  • Tolerance in transit describes the chemical stability of a dry solid, not any property after the vial is opened.

Questions

Does a lyophilized peptide need to arrive cold?
Not for chemical stability over a few days. A dry, sealed solid changes slowly near room temperature; the larger transit risks are prolonged heat, moisture and condensation.
Why −20 °C rather than a refrigerator?
Reaction rates fall with temperature. The two- to four-fold per 10 °C rule applied to the roughly 24 °C gap between −20 °C and a refrigerator near 4 °C gives roughly an order of magnitude, an extrapolation from a room-temperature rule and not a measured value for any lot.
What happens if a vial taken from −20 °C is opened immediately?
Water vapour condenses onto the cold cake, which can soften it and raise residual moisture. Equilibrating the sealed vial first avoids this.

References

  1. Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. Journal of Pharmaceutical Sciences, 1999.
  2. Manning MC et al. Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 2010.
  3. Waterman KC, Adami RC. Accelerated aging: prediction of chemical stability of pharmaceuticals. International Journal of Pharmaceutics, 2005.
  4. Stability Testing of New Drug Substances and Products Q1A(R2). International Council for Harmonisation (ICH), 2003.

Every compound on this site is supplied as a lyophilized powder for laboratory research use only. Nothing in this article describes an effect on a person or is a claim about any product.

Ready when you are.

Thirty-one compounds and blends, labelled plainly and shipped from Canada.